Steve Mazan, Laugh and Learn, June 2018

Laugh and Learn with Comedian Steve Mazan

May 30, 2018

Come and laugh with Steve Mazan, stand-up comedian, inspirational speaker, and 13-year NET cancer survivor. “CS Happens” is a Laugh and Learn special evening for the NET community, and is complementary courtesy of Lexicon Pharmaceuticals. This unique…

READ MORE
Amit Tirosh, MD_2

Endocrinology Society Recognizes Neuroendocrine Cancer Physician and Researcher for Excellence at 2018 Annual Meeting

April 15, 2018

When Amit Tirosh, MD came to the United States in 2015 to be a senior endocrinologist at the National Institutes of Health (NIH), he began a journey that will lead full circle when he returns to Israel this summer to establish and lead a new neuroendocrine

READ MORE
Edward Wolin, MD_3

June Luncheon with the Experts in New York City for the Neuroendocrine Tumor Community

April 3, 2018

Join neuroendocrine tumor (NET) patients in New York City on Sunday, June 10, 2018 for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues ranging…

READ MORE
FDA approval_3

PRRT – FDA Approves Lutathera®, What’s Next?

February 20, 2018

The FDA approval of Lutathera®, a peptide receptor radionuclide therapy (PRRT), on January 26, 2018 signals a new era in treatment options for the neuroendocrine cancer community.  It has also raised a host of questions including:

  • What exactly is this
READ MORE
ZebraTales_Stacie Chevrier_Instagram

Zebra Tales: Carcinoid NETs Health Storylines Launches New Feature

February 15, 2018

Carcinoid NETs Health Storylines presents Zebra Tales! This brand new feature enables you to learn and share more about the experiences of others within the neuroendocrine tumor (NET) community.

Our first inspiring story is from Stacie Chevrier –…

READ MORE
Lu-177

FDA Approves LUTATHERA® for Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

January 26, 2018

BREAKING NEWS: On January 26, 2018 the US Food and Drug Administration approved LUTATHERA® marking the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of gastroenteropancreatic neuroendocrine tumors

READ MORE
Edward Wolin, Matthew Kulke, Pamela Kunz, Yi-Zarn Wang

News about Neuroendocrine Cancer Expert Physicians

January 8, 2018

Three appointments and a newly established one-year neuroendocrine tumor (NET) fellowship herald an exciting new year for several NET specialists.

Edward M. Wolin, MD, Co-Medical Director of the Carcinoid Cancer Foundation, has been named Director

READ MORE
MonicaWarner(2)

8th Annual Warner Advocacy Award: Call for Nominations

November 14, 2017

Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize …

READ MORE
Bicycle

NET Community Bicycle Raffle Recipients

November 10, 2017

In conjunction with Worldwide NET Cancer Awareness Day, November 10, the Carcinoid Cancer Foundation and Advanced Accelerator Applications are very excited to announce recipients of the recent Bicycle Giveaway Raffle.

Stefano Buono, CEO of Advanced…

READ MORE
Carcinoid Syndrome Web Series 2017_2

Nutrition for Neuroendocrine Tumors and Carcinoid Syndrome: Find Foods You Love!

October 11, 2017

Are you wondering what are the best foods to eat if you have carcinoid syndrome?  What changes should you make to your diet if you have neuroendocrine tumors? The neuroendocrine tumor (NET) community is invited to attend a national webcast on Wednesday,

READ MORE